Skip to main content
. Author manuscript; available in PMC: 2020 Dec 21.
Published in final edited form as: Clin Exp Hypertens. 2018 Feb 9;41(1):5–13. doi: 10.1080/10641963.2018.1433197

Figure 5. Vasodilator-stimulated phosphoprotein (VASP)—transient receptor potential channel 4 (TRPC4) interaction in response to NO donor.

Figure 5.

A, TRPC4 expression under basal conditions in mesenteric vessels from vehicle (V), L-buthionine sulfoximine (BSO), tempol (T) and BSO + T -treated rats. B, mesenteric vessels were incubated with diethylenetriamine NONOate (DETA NONOate) followed by immunoprecipitation by VASP and phosphorylated VASP (P-VASP) antibodies. The immunoprecipitates were immunoblotted for TRPC4. Bars represent mean ± SE from 6–8 rats performed in triplicate. *P<0.05 vs. V and #P<0.05 vs. BSO, using 1-way ANOVA followed by post hoc Newman-Keuls multiple test.